Nadine M. Tung, M.D.
Assistant Professor, Department of Medicine, Harvard Medical School
Director, Cancer Risk and Prevention Program, Beth Israel Deaconess Medical Center
Contact Info
Nadine Tung
Beth Israel Deaconess Medical Center
330 Brookline Avenue
Boston, MA, 02215
Phone: 617-667-7081
Fax: 617-975-5665
ntung@caregroup.harvard.edu
Beth Israel Deaconess Medical Center
330 Brookline Avenue
Boston, MA, 02215
Phone: 617-667-7082
sparla@caregroup.harvard.edu
Beth Israel Deaconess Medical Center
330 Brookline Avenue
Boston, MA, 02215
Phone: 617-667-7081
Fax: 617-975-5665
ntung@caregroup.harvard.edu
Assistant
Susan ParlaBeth Israel Deaconess Medical Center
330 Brookline Avenue
Boston, MA, 02215
Phone: 617-667-7082
sparla@caregroup.harvard.edu
DF/HCC Program Affiliation
Breast CancerGynecologic Cancer
Cancer Genetics
Research Abstract
My research is in the area of breast imaing and ovarian cancer treatment, prevention and genetics. I am involved in several projects evaluating the incidence of BRCA1/BRCA2 in various populations and investigating how hormonal and environmental factors affect cancer expression in mutation carriers. I am also interested in the efficacy of various screening modalities (e.g. MRI) in BRCA1/BRCA2 mutation carriers. I conduct treatment trials in breast and ovarian cancer.Publications
- McLaughlin JR, Risch HA, Lubinski J, Moller P, Ghadirian P, Lynch H, Karlan B, Fishman D, Rosen B, Neuhausen SL, Offit K, Kauff N, Domchek S, Tung N, Friedman E, Foulkes W, Sun P, Narod SA,.Reproductive risk factors for ovarian cancer in carriers of BRCA1
17196508 - Finch A, Beiner M, Lubinski J, Lynch HT, Moller P, Rosen B, Murphy J, Ghadirian P, Friedman E, Foulkes WD, Kim-Sing C, Wagner T, Tung N, Couch F, Stoppa-Lyonnet D, Ainsworth P, Daly M, Pasini B, Gershoni-Baruch R, Eng C, Olopade OI, McLennan J, Karlan B,
16835424 - Friedman E, Kotsopoulos J, Lubinski J, Lynch HT, Ghadirian P, Neuhausen SL, Isaacs C, Weber B, Foulkes WD, Moller P, Rosen B, Kim-Sing C, Gershoni-Baruch R, Ainsworth P, Daly M, Tung N, Eisen A, Olopade OI, Karlan B, Saal HM, Garber JE, Rennert G, Gilchri
16563180 - Gronwald J, Tung N, Foulkes WD, Offit K, Gershoni R, Daly M, Kim-Sing C, Olsson H, Ainsworth P, Eisen A, Saal H, Friedman E, Olopade O, Osborne M, Weitzel J, Lynch H, Ghadirian P, Lubinski J, Sun P, Narod SA,.Tamoxifen and contralateral breast cancer in B
16331614 - Nkondjock A, Ghadirian P, Kotsopoulos J, Lubinski J, Lynch H, Kim-Sing C, Horsman D, Rosen B, Isaacs C, Weber B, Foulkes W, Ainsworth P, Tung N, Eisen A, Friedman E, Eng C, Sun P, Narod SA.Coffee consumption and breast cancer risk among BRCA1 and BRCA2 mu
16032702 - Cullinane CA, Lubinski J, Neuhausen SL, Ghadirian P, Lynch HT, Isaacs C, Weber B, Moller P, Offit K, Kim-Sing C, Friedman E, Randall S, Pasini B, Ainsworth P, Gershoni-Baruch R, Foulkes WD, Klijn J, Tung N, Rennert G, Olopade O, Couch F, Wagner T, Olsson
15986445




